Company / Net Income
Kymera Therapeutics, Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$311.4M
FY2025
5-year range
-$311.4M / -$41.2M
FY2021-FY2025
Trend
-39.1%
vs FY2024
Sector context
#179 of 216
Health Care
What the data says
Kymera Therapeutics, Inc.'s net income of -$311M is lower than 83% of companies in the Health Care sector (FY2025). Declined from -$147M to -$311M over the past 2 years.
Based on SEC 10-K filings.
-$311M in FY2025.
Declined from -$147M to -$311M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 216This company -$311.4M Sector average $454.1M
▼
-168.6% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 39.1% year-over-year.
- Ranks #179 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$311.4M | -39.1% |
| FY2024 | -$223.9M | -52.3% |
| FY2023 | -$147.0M | +5.1% |
| FY2022 | -$154.8M | -275.3% |
| FY2021 | -$41.2M | +0.0% |
| FY2020 | -$41.2M | +0.0% |
| FY2019 | -$41.2M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026